A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
Conditions: Chronic Kidney Disease; Chronic Renal FailureInterventions: Biological: Epoetin Hospira; Biological: Epogen (Amgen)Sponsor: Hospira, Inc.Completed - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anemia | Dialysis | Epogen | Hemodialysis | Procrit | Renal Failure | Research | Study | Urology & Nephrology